{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:06:08Z","timestamp":1773450368916,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007172","name":"Cincinnati Children's Hospital Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cancergen.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:50:28Z","timestamp":1771401028000},"page":"162-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["DNMT3A R882C variant in a patient with a presumed pineal gland tumor, highlighting potential tumor susceptibility in Tatton-Brown-Rahman syndrome"],"prefix":"10.1016","volume":"302-303","author":[{"given":"Leonardo","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1160-9842","authenticated-orcid":false,"given":"Scott I","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-0652","authenticated-orcid":false,"given":"Sun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cancergen.2026.02.005_bib0001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng.2917","article-title":"Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability","volume":"46","author":"Tatton-Brown","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2026.02.005_bib0002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.12688\/wellcomeopenres.14430.1","article-title":"The Tatton-Brown-Rahman syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants","volume":"3","author":"Tatton-Brown","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"12","key":"10.1016\/j.cancergen.2026.02.005_bib0003","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41431-023-01459-w","article-title":"Methylation signatures in clinically variable syndromic disorders: a familial DNMT3A variant in two adults with Tatton-Brown-Rahman syndrome","volume":"31","author":"Kumps","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"18","key":"10.1016\/j.cancergen.2026.02.005_bib0004","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1093\/nar\/gkw723","article-title":"Allosteric control of mammalian DNA methyltransferases - a new regulatory paradigm","volume":"44","author":"Jeltsch","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.cancergen.2026.02.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009570","article-title":"The DNMT3A PWWP domain is essential for the normal DNA methylation landscape in mouse somatic cells and oocytes","volume":"17","author":"Kibe","year":"2021","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.cancergen.2026.02.005_bib0006","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1038\/s41467-024-47699-2","article-title":"Combined and differential roles of ADD domains of DNMT3A and DNMT3L on DNA methylation landscapes in mouse germ cells","volume":"15","author":"Kubo","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cancergen.2026.02.005_bib0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2199-4-7","article-title":"Interactions within the mammalian DNA methyltransferase family","volume":"4","author":"Margot","year":"2003","journal-title":"BMC Mol Biol"},{"issue":"2","key":"10.1016\/j.cancergen.2026.02.005_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32020088","article-title":"The role of the DNA methyltransferase family and the therapeutic potential of DNMT inhibitors in tumor treatment","volume":"32","author":"Kim","year":"2025","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.02.005_bib0009","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/2159-8290.CD-21-0560","article-title":"Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor","volume":"12","author":"Huang","year":"2022","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.cancergen.2026.02.005_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010008","article-title":"Functional analysis of DNMT3A DNA methyltransferase mutations reported in patients with acute myeloid leukemia","volume":"10","author":"Khrabrova","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.cancergen.2026.02.005_bib0011","series-title":"Tatton-Brown-Rahman Syndrome, in GeneReviews((R))","author":"Ostrowski","year":"1993"},{"key":"10.1016\/j.cancergen.2026.02.005_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-017-0081-z","article-title":"DNA methyltransferases and their roles in tumorigenesis","volume":"5","author":"Zhang","year":"2017","journal-title":"Biomark Res"},{"issue":"3","key":"10.1016\/j.cancergen.2026.02.005_bib0013","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood.2021014052","article-title":"DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults","volume":"139","author":"Ferris","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cancergen.2026.02.005_bib0014","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11102-019-01019-w","article-title":"Acromegaly in the setting of Tatton-Brown-Rahman syndrome","volume":"23","author":"Hage","year":"2020","journal-title":"Pituitary"},{"issue":"25","key":"10.1016\/j.cancergen.2026.02.005_bib0015","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cancergen.2026.02.005_bib0016","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/ajmg.a.61180","article-title":"The first case report of medulloblastoma associated with Tatton-Brown-Rahman syndrome","volume":"179","author":"Sweeney","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.cancergen.2026.02.005_bib0017","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41431-019-0485-3","article-title":"Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients","volume":"28","author":"Tenorio","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.cancergen.2026.02.005_bib0018","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ajmg.a.61475","article-title":"Tatton-Brown-Rahman syndrome: six individuals with novel features","volume":"182","author":"Balci","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.cancergen.2026.02.005_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.31486\/toj.18.0110","article-title":"Biomarkers of pineal region tumors: a review","volume":"19","author":"Carr","year":"2019","journal-title":"Ochsner J"},{"issue":"6","key":"10.1016\/j.cancergen.2026.02.005_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/PAP.0b013e3181f895a4","article-title":"Pineal tumors","volume":"17","author":"Dahiya","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"7","key":"10.1016\/j.cancergen.2026.02.005_bib0021","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1148\/rg.307105131","article-title":"From the archives of the AFIP: lesions of the pineal region: radiologic-pathologic correlation","volume":"30","author":"Smith","year":"2010","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.cancergen.2026.02.005_bib0022","doi-asserted-by":"crossref","first-page":"E420","DOI":"10.1093\/neuros\/nyz062","article-title":"Papillary tumor of the pineal region: systematic review and analysis of prognostic factors","volume":"85","author":"Yamaki","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.cancergen.2026.02.005_bib0023","article-title":"Papillary tumor of the pineal region: MR signal intensity correlated to histopathology","volume":"2015","author":"Rosa Junior","year":"2015","journal-title":"Case Rep Neurol Med"},{"issue":"1","key":"10.1016\/j.cancergen.2026.02.005_bib0024","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajmg.a.37995","article-title":"Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation","volume":"173","author":"Kosaki","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"14","key":"10.1016\/j.cancergen.2026.02.005_bib0025","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1158\/0008-5472.CAN-18-3275","article-title":"A model system for studying the DNMT3A hotspot mutation (DNMT3A(R882)) demonstrates a causal relationship between its dominant-negative effect and leukemogenesis","volume":"79","author":"Lu","year":"2019","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.cancergen.2026.02.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113411","article-title":"Distinct disease mutations in DNMT3A result in a spectrum of behavioral, epigenetic, and transcriptional deficits","volume":"42","author":"Beard","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.cancergen.2026.02.005_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fncel.2017.00023","article-title":"Epigenetic modulation of stem cells in neurodevelopment: the role of methylation and acetylation","volume":"11","author":"Podobinska","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"10.1016\/j.cancergen.2026.02.005_bib0028","article-title":"Dynamic regulation of DNA methylation and brain functions","volume":"12","author":"Xie","year":"2023","journal-title":"Biology (Basel)"},{"issue":"3","key":"10.1016\/j.cancergen.2026.02.005_bib0029","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neuroscience.2006.07.053","article-title":"Transition of mouse de novo methyltransferases expression from Dnmt3b to Dnmt3a during neural progenitor cell development","volume":"142","author":"Watanabe","year":"2006","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.cancergen.2026.02.005_bib0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4161\/epi.28324","article-title":"The de novo DNA methyltransferase DNMT3A in development and cancer","volume":"9","author":"Chen","year":"2014","journal-title":"Epigenetics"},{"issue":"12","key":"10.1016\/j.cancergen.2026.02.005_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003146","article-title":"Dnmt3a protects active chromosome domains against cancer-associated hypomethylation","volume":"8","author":"Raddatz","year":"2012","journal-title":"PLoS Genet"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776226000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776226000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:47:11Z","timestamp":1773449231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776226000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S2210776226000256"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2026.02.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNMT3A R882C variant in a patient with a presumed pineal gland tumor, highlighting potential tumor susceptibility in Tatton-Brown-Rahman syndrome","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}